Ki-Young Jung Selected Research

Oxcarbazepine (Trileptal)

10/2018	Increased adverse events associated with antiepileptic drugs in anti-leucine-rich glioma-inactivated protein 1 encephalitis.
3/2017	Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
11/2016	HLA-B40:02 and DRB104:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
6/2013	Effect of oxcarbazepine on background EEG activity and cognition in epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ki-Young Jung Research Topics

Disease

21	Epilepsy (Aura) 01/2022 - 09/2008
8	Seizures (Absence Seizure) 01/2022 - 01/2002
6	Encephalitis (Encephalitis, Rasmussen) 10/2018 - 01/2016
5	Cognitive Dysfunction 11/2021 - 06/2013
5	Restless Legs Syndrome (Restless Legs) 01/2021 - 12/2013
5	Autoimmune Diseases of the Nervous System 01/2018 - 01/2016
4	REM Sleep Behavior Disorder 02/2022 - 04/2019
4	Sleep Initiation and Maintenance Disorders (Insomnia) 02/2022 - 01/2016
4	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 02/2017 - 12/2015
3	Exanthema (Rash) 01/2021 - 10/2018
3	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2015
3	Drug-Related Side Effects and Adverse Reactions 01/2017 - 10/2015
3	Status Epilepticus (Complex Partial Status Epilepticus) 12/2015 - 05/2003
2	Neoplasms (Cancer) 01/2022 - 09/2014
2	Temporal Lobe Epilepsy 03/2021 - 07/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
2	Bacterial Meningitis 01/2021 - 09/2019
2	Synucleinopathies 11/2020 - 11/2019
2	Hypoxia (Hypoxemia) 11/2020 - 10/2020
2	Inflammation (Inflammations) 11/2020 - 05/2018
2	Orthostatic Hypotension (Postural Hypotension) 01/2020 - 09/2017
2	Postural Orthostatic Tachycardia Syndrome 05/2019 - 01/2018
2	Partial Epilepsies (Epilepsy, Partial) 01/2019 - 01/2002
2	Glioma (Gliomas) 10/2018 - 02/2017
2	Orthostatic Intolerance 09/2018 - 01/2018
2	Generalized Epilepsy 01/2018 - 01/2017
2	Cerebellar Ataxia (Dysmetria) 01/2017 - 12/2006
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 11/2016 - 10/2015
2	Migraine Disorders (Migraine) 03/2016 - 01/2013
2	Headache (Headaches) 03/2016 - 01/2012
2	Nervous System Diseases (Neurological Disorders) 01/2016 - 04/2015
2	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2016 - 04/2015
2	Stiff-Person Syndrome (Stiff Man Syndrome) 09/2014 - 12/2006
1	Disorders of Excessive Somnolence (Hypersomnia) 02/2022
1	Brain Neoplasms (Brain Tumor) 01/2022
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2021
1	Meningitis 01/2021
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2020
1	Iron Deficiencies 11/2020
1	Sleep Deprivation 10/2020
1	Obstructive Sleep Apnea 10/2020
1	Glucose Intolerance 10/2020
1	Schizophrenia (Dementia Praecox) 01/2020
1	Prodromal Symptoms 11/2019
1	Epileptic Syndromes 01/2019
1	Disease Progression 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Hyponatremia 10/2018
1	Eczema 10/2018

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 03/2021 - 09/2010
11	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
4	Pilocarpine (Ocusert)FDA LinkGeneric 01/2020 - 05/2003
4	Oxcarbazepine (Trileptal)FDA LinkGeneric 10/2018 - 06/2013
4	Levetiracetam (Keppra)FDA LinkGeneric 10/2018 - 01/2017
4	AntibodiesIBA 01/2018 - 04/2015
3	Interleukin-2 (IL2)IBA 01/2022 - 01/2016
3	CytokinesIBA 01/2022 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
3	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 10/2015
3	Proteins (Proteins, Gene)FDA Link 11/2020 - 10/2017
3	Rituximab (Mabthera)FDA Link 10/2016 - 01/2016
2	MelatoninIBA 02/2022 - 04/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2016
2	perampanelIBA 01/2021 - 01/2021
2	phenyl-2-aminoethyl sulfide (PAES)IBA 12/2020 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020 - 05/2019
2	Glucose (Dextrose)FDA LinkGeneric 10/2020 - 10/2017
2	Midodrine (Midon)FDA LinkGeneric 01/2020 - 09/2017
2	Interleukin-10 (Interleukin 10)IBA 11/2019 - 01/2016
2	Circular RNAIBA 01/2019 - 01/2018
2	Leucine (L-Leucine)FDA Link 10/2018 - 02/2017
2	hydroxide ionIBA 09/2018 - 09/2017
2	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2015
2	SteroidsIBA 01/2018 - 12/2006
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2018 - 09/2017
2	Topiramate (Topamax)FDA LinkGeneric 03/2017 - 09/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2017 - 12/2015
2	Long Noncoding RNAIBA 01/2017 - 07/2015
2	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2016 - 12/2006
1	Clonazepam (Rivotril)FDA LinkGeneric 02/2022
1	Zolpidem (Ambien)FDA LinkGeneric 01/2022
1	Hypnotics and Sedatives (Sedatives)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 11/2021
1	ApolipoproteinsIBA 11/2021
1	CoagulaseIBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	Complement C4aIBA 11/2020
1	Complement C3 (C3 Complement)IBA 11/2020
1	IronIBA 11/2020
1	Blood Glucose (Blood Sugar)IBA 10/2020
1	Atomoxetine Hydrochloride (Strattera)FDA LinkGeneric 01/2020
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Celecoxib (Celebrex)FDA Link 01/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 09/2008
8	Immunotherapy 01/2018 - 04/2015
3	Aftercare (After-Treatment) 01/2018 - 09/2008
1	Anterior Temporal Lobectomy 03/2021
1	Precision Medicine 01/2019